58545-48-5

Basic information

• Product Name: (E)-1,3-dimethoxy-5-(pent-1-en-1-yl)benzene
• Synonyms: (E)-1,3-dimethoxy-5-(pent-1-en-1-yl)benzene
• CAS NO: 58545-48-5
• Molecular Weight: 206.285
• Mol File: 58545-48-5.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: (E)-1,3-dimethoxy-5-(pent-1-en-1-yl)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-1,3-dimethoxy-5-(pent-1-en-1-yl)benzene(58545-48-5)
• EPA Substance Registry System: (E)-1,3-dimethoxy-5-(pent-1-en-1-yl)benzene(58545-48-5)

Safety Data

• Hazardous Substances Data: 58545-48-5(Hazardous Substances Data)

Upstream product

• 38228-28-3 1-(1-hydroxypentyl)-3,5-dimethoxybenzene 
• 7311-34-4 3,5-dimethoxybenzaldehdye 
• 123-72-8 butyraldehyde 
• 108957-75-1 diethyl 3,5-dimethoxybenzylphosphonate 
• 5333-29-9 1-(3,5-dimethoxy-phenyl)-pentan-1-one 
• 1779-51-7 n-butyl(triphenyl)phosphonium bromide 

Downstream Products

• 22976-40-5 1,3-dimethoxy-5-pentylbenzene 
• 865314-76-7 (E)-5-methoxy-7-pentyl-3-styryl-2H-chromene 
• 3410-84-2 2,6-dimethoxy-4-pentylbenzaldehyde 
• 162330-77-0 2-hydroxy-6-methoxy-4-pentylbenzaldehyde 
• 171569-34-9 1,3-dimethoxy-5-<14'-(3'',5''-dimethoxyphenyl)-cis-6'-tetradecenyl>benzene 
• 171569-33-8 1,3-dimethoxy-5-<14'-(3'',5''-dimethoxyphenyl)-6'-tetradecynyl>benzene 
• 52483-24-6 1,3-dihydroxy-5-<14'-(3'',5''-dihydroxyphenyl)tetradec-cis-6'-enyl>benzene 
• 50873-97-7 1,3-dimethoxy-5-(6'-heptynyl)benzene 
• 886-52-2 5-(5'-bromopentyl)-1,3-dimethoxybenzene 
• 21390-07-8 1,3-dimethoxy-5-<14'-(3'',5''-dimethoxyphenyl)tetradecyl>benzene 
• 26050-60-2 1,3-dihydroxy-5-<14'-(3'',5''-dihydroxyphenyl)tetradecyl>benzene 
• 836-27-1 1,3-dimethoxy-5-(5-hydroxypentyl)benzene 

Relevant articles and documents

Design of Negative and Positive Allosteric Modulators of the Cannabinoid CB2Receptor Derived from the Natural Product Cannabidiol

Cannabidiol (CBD), the second most abundant of the active compounds found in the Cannabis sativa plant, is of increasing interest because it is approved for human use and is neither euphorizing nor addictive. Here, we design and synthesize novel compounds taking into account that CBD is both a partial agonist, when it binds to the orthosteric site, and a negative allosteric modulator, when it binds to the allosteric site of the cannabinoid CB2 receptor. Molecular dynamic simulations and site-directed mutagenesis studies have identified the allosteric site near the receptor entrance. This knowledge has permitted to perform structure-guided design of negative and positive allosteric modulators of the CB2 receptor with potential therapeutic utility.

Solid-Phase Reactive Chromatography (SPRC): A new methodology for wittig and horner-emmons reactions on a column under microwave irradiation

A new methodology named solid-phase reactive chromatography (SPRC), which combines reaction, separation, and purification into a single unit for the preparation of small samples, is described. This method was illustrated in the synthesis of some natural bioactive compounds, namely, methoxylated analogues of resveratrol, alkylresorcinols, and 5-aryl-2,4-pentadienoates, over a column of alumina-KF under microwave irradiation by using the Wittig and HornerEmmons reactions. This approach permitted the preparation of the target olefins with high purity and good to excellent yields in short reaction times.

Synthesis of both enantiomers of hiburipyranone

Both enentiomers of hiburipyranone, a cytotoxic metabolite of marine sponge, was synthesized employing Sharpless' asymmetric dihydroxylation as a key step and absolute configuration of the natural compound at C-3 position was determined to be R.